BB
BAKER BROS. ADVISORS LP
NEW YORK NY · SEC CIK 0001263508
$19.96B2026Q2 reported value
84Positions
72.8%Top 10 weight · largest 17.5%
6 / 8New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
RVMD Added+$353.58M
INSM Added+$146.60M
IDYA Added+$39.64M
FTH New+$32.16M
RLAY Added+$31.18M
2026Q2 top sells estimated at quarter-end value
EWTX Reduced-$116.78M
ABVX Sold out-$97.52M
SMMT Reduced-$52.52M
SYRE Sold out-$50.44M
Centessa Pharmac Sold out-$26.64M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | $3.49B | 17.48% | 30,762,330 | 17,918 | 0.1% | $2.03M | Added |
| ONC | BeOne Medicines Ltd. | $2.51B | 12.57% | 8,801,567 | 2,514 | 0.0% | $716,415 | Added |
| RVMD | Revolution Medicines, Inc. | $2.14B | 10.74% | 11,443,357 | 1,888,000 | 19.8% | $353.58M | Added |
| MDGL | Madrigal Pharmaceuticals, Inc. | $1.15B | 5.77% | 2,143,131 | 1,430 | 0.1% | $767,838 | Added |
| ACAD | ACADIA Pharmaceuticals Inc. | $1.09B | 5.44% | 42,912,904 | 16,214 | 0.0% | $410,214 | Added |
| KYMR | Kymera Therapeutics, Inc. | $992.73M | 4.97% | 8,657,242 | 0 | 0.0% | — | Unchanged |
| INSM | Insmed Incorporated | $937.84M | 4.70% | 8,796,111 | 1,375,000 | 18.5% | $146.60M | Added |
| CELC | Celcuity Inc. | $828.15M | 4.15% | 7,915,792 | 0 | 0.0% | — | Unchanged |
| KOD | Kodiak Sciences Inc. | $776.05M | 3.89% | 19,919,186 | 0 | 0.0% | — | Unchanged |
| RYTM | Rhythm Pharmaceuticals, Inc. | $622.27M | 3.12% | 5,604,483 | 0 | 0.0% | — | Unchanged |
| PRAX | Praxis Precision Medicines, Inc. | $586.95M | 2.94% | 1,753,198 | 0 | 0.0% | — | Unchanged |
| ALKS | Alkermes plc | $524.59M | 2.63% | 10,012,267 | 0 | 0.0% | — | Unchanged |
| SMMT | Summit Therapeutics Inc. | $477.70M | 2.39% | 32,786,348 | -3,604,715 | -9.9% | -$52.52M | Reduced |
| GRAL | GRAIL, Inc. | $275.03M | 1.38% | 4,028,614 | 0 | 0.0% | — | Unchanged |
| ABCL | AbCellera Biologics Inc. | $259.15M | 1.30% | 33,012,138 | 2,736,200 | 9.0% | $21.48M | Added |
| IMVT | Immunovant, Inc. | $209.42M | 1.05% | 5,435,220 | -22,661 | -0.4% | -$873,128 | Reduced |
| IDYA | IDEAYA Biosciences, Inc. | $186.72M | 0.94% | 5,010,030 | 1,063,515 | 26.9% | $39.64M | Added |
| KNSA | Kiniksa Pharmaceuticals International, plc | $181.28M | 0.91% | 2,834,643 | 8,397 | 0.3% | $536,988 | Added |
| ROIV | Roivant Sciences Ltd. | $166.93M | 0.84% | 4,716,831 | -150,892 | -3.1% | -$5.34M | Reduced |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $162.43M | 0.81% | 1,992,783 | 0 | 0.0% | — | Unchanged |
| IONS | Ionis Pharmaceuticals, Inc. | $162.36M | 0.81% | 2,047,727 | 0 | 0.0% | — | Unchanged |
| EWTX | Edgewise Therapeutics, Inc. | $150.40M | 0.75% | 3,701,719 | -2,874,221 | -43.7% | -$116.78M | Reduced |
| REPL | Replimune Group, Inc. | $122.27M | 0.61% | 11,045,336 | 0 | 0.0% | — | Unchanged |
| NRIX | Nurix Therapeutics, Inc. | $113.02M | 0.57% | 4,658,556 | 0 | 0.0% | — | Unchanged |
| STOK | Stoke Therapeutics, Inc. | $109.18M | 0.55% | 3,336,697 | 0 | 0.0% | — | Unchanged |
| GLUE | Monte Rosa Therapeutics, Inc. | $105.17M | 0.53% | 4,345,736 | 0 | 0.0% | — | Unchanged |
| IMTX | Immatics N.V. | $96.32M | 0.48% | 9,508,565 | -1,408,128 | -12.9% | -$14.26M | Reduced |
| DNLI | Denali Therapeutics Inc. | $96.05M | 0.48% | 3,734,336 | 2,641 | 0.1% | $67,927 | Added |
| — | Crinetics Pharmaceuticals, Inc. | $87.99M | 0.44% | 2,351,465 | 0 | 0.0% | — | Unchanged |
| DNTH | Dianthus Therapeutics, Inc. | $83.07M | 0.42% | 852,164 | 0 | 0.0% | — | Unchanged |
| GPCR | Structure Therapeutics Inc. | $76.88M | 0.39% | 1,432,529 | 0 | 0.0% | — | Unchanged |
| CELC | Celcuity Inc. | $69.16M | 0.35% | 30,750,000 | 0 | 0.0% | — | Unchanged |
| RAPP | Rapport Therapeutics, Inc. | $64.47M | 0.32% | 1,547,090 | 0 | 0.0% | — | Unchanged |
| ALMS | Alumis Inc. | $56.63M | 0.28% | 2,012,500 | 0 | 0.0% | — | Unchanged |
| PRLD | Prelude Therapeutics Inc. | $53.96M | 0.27% | 10,123,824 | 0 | 0.0% | — | Unchanged |
| RLAY | Relay Therapeutics, Inc. | $52.89M | 0.27% | 2,826,783 | 1,666,666 | 143.7% | $31.18M | Added |
| MIRM | Mirum Pharmaceuticals, Inc. | $52.21M | 0.26% | 445,975 | 0 | 0.0% | — | Unchanged |
| BCYC | Bicycle Therapeutics plc | $46.15M | 0.23% | 10,885,357 | 0 | 0.0% | — | Unchanged |
| ELVN | Enliven Therapeutics, Inc. | $45.94M | 0.23% | 905,191 | 0 | 0.0% | — | Unchanged |
| CLDX | Celldex Therapeutics, Inc. | $44.00M | 0.22% | 1,182,611 | 517,241 | 77.7% | $19.25M | Added |
| VRDN | Viridian Therapeutics, Inc. | $43.78M | 0.22% | 2,383,025 | 411,347 | 20.9% | $7.56M | Added |
| DSGN | Design Therapeutics, Inc. | $38.76M | 0.19% | 2,678,430 | 92,452 | 3.6% | $1.34M | Added |
| TRDA | Entrada Therapeutics, Inc. | $37.34M | 0.19% | 5,072,730 | 0 | 0.0% | — | Unchanged |
| FTH | Faeth Therapeutics, Inc. | $32.16M | 0.16% | 1,286,411 | 1,286,411 | — | $32.16M | New |
| AKTS | Aktis Oncology, Inc. | $32.11M | 0.16% | 996,351 | 0 | 0.0% | — | Unchanged |
| NGNE | Neurogene Inc. | $31.19M | 0.16% | 991,691 | 0 | 0.0% | — | Unchanged |
| JBIO | Jade Biosciences, Inc. | $27.34M | 0.14% | 1,230,426 | -410,711 | -25.0% | -$9.13M | Reduced |
| TSHA | Taysha Gene Therapies, Inc. | $27.27M | 0.14% | 4,004,756 | 0 | 0.0% | — | Unchanged |
| RCUS | Arcus Biosciences, Inc. | $26.05M | 0.13% | 844,816 | 429,195 | 103.3% | $13.23M | Added |
| IRON | Disc Medicine, Inc. | $25.57M | 0.13% | 349,657 | 0 | 0.0% | — | Unchanged |
| ABSI | Absci Corporation | $24.74M | 0.12% | 2,134,803 | 0 | 0.0% | — | Unchanged |
| GENB | Generate Biomedicines, Inc. | $24.02M | 0.12% | 1,423,602 | 0 | 0.0% | — | Unchanged |
| DBVT | DBV Technologies S.A. | $23.97M | 0.12% | 1,461,425 | 0 | 0.0% | — | Unchanged |
| XENE | Xenon Pharmaceuticals Inc. | $22.35M | 0.11% | 370,208 | 0 | 0.0% | — | Unchanged |
| TECX | Tectonic Therapeutic, Inc. | $20.89M | 0.10% | 607,788 | 0 | 0.0% | — | Unchanged |
| CERS | Cerus Corporation | $18.67M | 0.09% | 6,395,431 | -3,612,914 | -36.1% | -$10.55M | Reduced |
| CTMX | CytomX Therapeutics, Inc. | $18.66M | 0.09% | 4,975,826 | 0 | 0.0% | — | Unchanged |
| DYN | Dyne Therapeutics, Inc. | $18.07M | 0.09% | 813,449 | 0 | 0.0% | — | Unchanged |
| CYTK | Cytokinetics, Incorporated | $18.00M | 0.09% | 211,267 | 211,267 | — | $18.00M | New |
| XNCR | Xencor, Inc. | $17.74M | 0.09% | 1,102,106 | 0 | 0.0% | — | Unchanged |
| SION | Sionna Therapeutics, Inc. | $17.60M | 0.09% | 400,000 | 0 | 0.0% | — | Unchanged |
| NTLA | Intellia Therapeutics, Inc. | $15.74M | 0.08% | 930,232 | 930,232 | — | $15.74M | New |
| PBLS | Parabilis Medicines, Inc. | $13.69M | 0.07% | 500,000 | 500,000 | — | — | First reported |
| MPLT | MapLight Therapeutics, Inc. | $13.07M | 0.07% | 364,705 | 0 | 0.0% | — | Unchanged |
| AVLN | Avalyn Pharma Inc. | $11.52M | 0.06% | 350,000 | 350,000 | — | — | First reported |
| EVMN | Evommune, Inc. | $11.26M | 0.06% | 847,390 | 0 | 0.0% | — | Unchanged |
| BNTX | BioNTech SE | $11.14M | 0.06% | 119,743 | 0 | 0.0% | — | Unchanged |
| TNGX | Tango Therapeutics, Inc. | $10.42M | 0.05% | 333,333 | 333,333 | — | $10.42M | New |
| AVTX | Avalo Therapeutics, Inc. | $10.16M | 0.05% | 550,000 | 550,000 | — | $10.16M | New |
| — | Sera Prognostics, Inc. | $10.01M | 0.05% | 5,498,170 | 0 | 0.0% | — | Unchanged |
| VSTM | Verastem, Inc. | $9.55M | 0.05% | 2,499,338 | 1,914,581 | 327.4% | $7.31M | Added |
| SGMT | Sagimet Biosciences Inc. | $7.37M | 0.04% | 952,996 | 0 | 0.0% | — | Unchanged |
| EIKN | Eikon Therapeutics, Inc. | $7.25M | 0.04% | 555,555 | 0 | 0.0% | — | Unchanged |
| LBRX | LB Pharmaceuticals Inc. | $6.49M | 0.03% | 200,000 | 0 | 0.0% | — | Unchanged |
| — | vTv Therapeutics, Inc. | $5.58M | 0.03% | 148,314 | 0 | 0.0% | — | Unchanged |
| WVE | Wave Life Sciences Ltd. | $4.78M | 0.02% | 822,638 | 0 | 0.0% | — | Unchanged |
| TARA | Protara Therapeutics, Inc. | $3.71M | 0.02% | 971,614 | 0 | 0.0% | — | Unchanged |
| — | TScan Therapeutics, Inc. | $2.73M | 0.01% | 2,784,792 | 0 | 0.0% | — | Unchanged |
| IMNM | Immunome, Inc. | $1.17M | 0.01% | 55,306 | 55,306 | — | $1.17M | New |
| — | Skye Bioscience, Inc. | $1.09M | 0.01% | 1,575,243 | 0 | 0.0% | — | Unchanged |
| SANA | Sana Biotechnology, Inc. | $1.08M | 0.01% | 310,483 | 0 | 0.0% | — | Unchanged |
| — | Aligos Therapeutics, Inc. | $479,227 | 0.00% | 83,055 | 0 | 0.0% | — | Unchanged |
| TYRA | Tyra Biosciences, Inc. | $338,788 | 0.00% | 10,607 | 0 | 0.0% | — | Unchanged |
| — | Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) | $13,750 | 0.00% | 833,333 | 0 | 0.0% | — | Unchanged |
| ABVX | Abivax S.A. | $0 | 0.00% | 0 | -875,796 | -100.0% | -$97.52M | Sold out |
| SYRE | Spyre Therapeutics, Inc. | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$50.44M | Sold out |
| — | Centessa Pharmaceuticals plc | $0 | 0.00% | 0 | -670,751 | -100.0% | -$26.64M | Sold out |
| IMCR | Immunocore Holdings plc | $0 | 0.00% | 0 | -734,397 | -100.0% | -$22.14M | Sold out |
| CTNM | Contineum Therapeutics, Inc. | $0 | 0.00% | 0 | -1,420,838 | -100.0% | -$18.56M | Sold out |
| ARGX | argenx SE | $0 | 0.00% | 0 | -25,174 | -100.0% | -$18.38M | Sold out |
| CMPS | COMPASS Pathways plc | $0 | 0.00% | 0 | -2,344,720 | -100.0% | -$12.97M | Sold out |
| PHVS | Pharvaris N.V. | $0 | 0.00% | 0 | -375,000 | -100.0% | -$10.59M | Sold out |